Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Psychopharmacological treatment of obsessive-compulsive disorder (OCD)

A Del Casale, S Sorice, A Padovano… - Current …, 2019 - ingentaconnect.com
Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …

[PDF][PDF] Practice guideline for the treatment of patients with obsessive-compulsive disorder

American Psychiatric Association, LM Koran… - 2007 - academia.edu
PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH OBSESSIVE-COMPULSIVE
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic …

B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2008 - Taylor & Francis
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

The pharmacologic treatment of anxiety disorders: a review of progress

LN Ravindran, MB Stein - The Journal of clinical psychiatry, 2010 - psychiatrist.com
Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines

S Pallanti, L Quercioli - Progress in Neuro-Psychopharmacology and …, 2006 - Elsevier
While controlled trials with SRIs have demonstrated a selective efficacy in obsessive-
compulsive disorder (OCD), up to 40–60% of patients do not have a satisfactory outcome …

[HTML][HTML] Treatment-resistant OCD: Pharmacotherapies in adults

PJ Van Roessel, G Grassi, EN Aboujaoude… - Comprehensive …, 2023 - Elsevier
Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

[PDF][PDF] Mapping compulsivity in the DSM-5 obsessive compulsive and related disorders: cognitive domains, neural circuitry, and treatment

NA Fineberg, AM Apergis-Schoute… - International Journal …, 2018 - academic.oup.com
Compulsions are repetitive, stereotyped thoughts and behaviors designed to reduce harm.
Growing evidence suggests that the neurocognitive mechanisms mediating behavioral …

Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and …

NM Batelaan, RC Bosman, A Muntingh, WD Scholten… - bmj, 2017 - bmj.com
Objectives To examine the risk of relapse and time to relapse after discontinuation of
antidepressants in patients with anxiety disorder who responded to antidepressants, and to …

Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders

D Denys - Psychiatric Clinics, 2006 - psych.theclinics.com
In addition to the open-mindedness of the authors, the surprising content of these
hypotheses illustrates how dramatically the attitude towards OCS has shifted in a few …